Among Targeting Microbiota 2016 VIP Speakers
Bioinformatics, integrating clinical and microbiome data: the challenge.
Examples from gut, oral and nasal microbiota in Parkinson’s disease
Velma Aho, University of Helsinki, Finland
Transition from an infant- to adult-like gut microbiota – where do the bacteria come from?
Ekaterina Avershina, Norway University of Life Sciences, Norway
Changing of skin and gut Microbiotas in ordinary life: cosmetics and bowel
Lorenzo Drago, University of Milan, Italy
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Paul Forsythe, McMaster University, Canada
Lactobacillus rhamnosus GG intake modifies preschool children’s intestinal microbiota, alleviates penicillin-associated changes and reduces antibiotic use
Katri Korpela, Helsinki University, Finland
Age-related immune senescence and microbiota dysbiosis: lessons from the fly
Henri Jasper, University of Rochester, USA
Impact of microbiota on odorant detection and olfactory preferences in mice
Nicolas Meunier, Neurobiologie de l'Olfaction et Blosenseur (NBO), INRA, France
Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance
Andrés Moya, University of Valencia, Spain
Faecalibacterium prausnitzii dynamics in the human gut microbiome underlying atopic dermatitis
Heenam Stanley Kim, Korea University, Republic of Korea
Maternal microbiota sets neonatal innate immune system development
Mercedes Gomez de Agüero, University of Bern, Switzerland
Microbiota & Bioinformatics: Strategic Targets
Sean Kennedy, Institut Pasteur, Paris
Emerging role of fecal microbiota therapy in the treatment of gastrointestinal diseases
Peter C. Konturek, Thuringia-Clinic Saalfeld, Germany
Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics
Roberto Pacifici, Emory University School of Medicine, USA
Tools and approaches to achieve strain resolution analyses of the microbiota
The gut microbiota mobilome and the potential of pathogen transmission of antibiotic resistance
Knut Rudi, Norway University of Life Sciences, Norway
Efficacy and mechanisms of action of fecal microbiota transplantation in ulcerative colitis: Pitfalls and promises from a first meta-analysis
Franco Scaldaferri, Catholic University of Sacred Hearth, Italy
Bacteriophages for improving human health: from food additives to dietary supplements
Alexander Sulakvelidze, Intralytix, USA
Mammals shape their microbiome to prevent disease: Recent Scientific advances & Perspectives
Howard Weiner, Harvard Medical School, USA
Important human microbial ecological system modulator - FMT (fecal microorganism transplantation) or one of the best clinical applications of epigenetics in gastroenterology
Diana Zandere, University of Riga, Latvia
Bacteriocin from epidemic Listeria strains alters the host intestinal microbiota to favor infection
Juan-Jose Quereda, Institut Pasteur, France
Response of gut bacteria to host starvation: understanding the risk factos to develop an eating disorder
Serguei Fetissov, Rouen University, France
To access to the preliminary program, please click here
